PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast CancerSamyuktha Suresh(Translational Research Institute), Thierry Dubois(Translational Research Institute)CancersJanuary 8, 202210.3390/cancers14020306Cited by 35SaveCiteExport RISWatch citationsRelated PapersFrequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells|Breast Cancer Research|2008|211TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer|PLoS ONE|2013|168Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells|PLoS ONE|2015|89LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers|Oncotarget|2018|33LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors|Cancer Medicine|2018|22